tACS for Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if transcranial alternating current stimulation (tACS) can improve language abilities in individuals with aphasia following a stroke. Participants will receive either real or sham tACS while engaging in language tasks, such as sentence completion and verb generation. The trial seeks individuals who have experienced a single stroke on the left side of the brain and continue to have language difficulties six months afterward. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could enhance language recovery methods.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have a history of significant or poorly controlled psychiatric disorders or current abuse of alcohol or drugs, you may not be eligible to participate.
What prior data suggests that tACS is safe for enhancing language abilities in people with post-stroke aphasia?
Research shows that transcranial alternating current stimulation (tACS) is generally safe. Past studies demonstrated that tACS helps stroke patients recover more effectively. Importantly, these studies did not find any serious side effects. Most people tolerate tACS well, with mild side effects such as slight itching or tingling on the scalp. This suggests that tACS is a well-tolerated treatment option for improving language skills in those with post-stroke aphasia.12345
Why are researchers excited about this trial?
Unlike standard treatments for aphasia, which often rely on speech therapy and medications, transcranial alternating current stimulation (tACS) offers a unique approach by using electrical currents to stimulate brain activity. Researchers are particularly excited about tACS because it delivers alternating currents in the alpha frequency band, which may enhance language processing by directly influencing brain waves. This method is non-invasive and can be precisely targeted, potentially providing a new avenue for improving language skills in people with aphasia.
What evidence suggests that tACS is effective for enhancing language abilities in post-stroke aphasia?
Research shows that transcranial alternating current stimulation (tACS) might improve language skills in people with speech difficulties after a stroke. This trial will assign participants to receive either real-tACS or sham-tACS. An earlier study found that those who received tACS had better speech understanding and increased blood flow in their brains. This suggests that tACS could enhance brain function to aid in recovering language skills. Although the results are promising, further studies are needed to confirm its effectiveness specifically for language problems after a stroke. Overall, tACS appears to offer a new method to help stroke survivors regain their ability to speak.12367
Are You a Good Fit for This Trial?
This trial is for right-handed individuals who have had a stroke in the left hemisphere of their brain at least 6 months ago and are now experiencing aphasia, which affects language abilities. They must understand the study and agree to participate.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive real and sham transcranial alternating current stimulation (tACS) in conjunction with language tests
Follow-up
Participants are monitored for language performance improvement and brain response to tACS
What Are the Treatments Tested in This Trial?
Interventions
- tACS
Trial Overview
Researchers are testing if active transcranial alternating current stimulation (tACS) can improve language skills in people with post-stroke aphasia. Participants will undergo real and sham tACS while performing language tests to measure effectiveness.
How Is the Trial Designed?
The active stimulation will consist of an alternating current delivered in the alpha frequency band with a peak-to-peak intensity of 4 milliamps (mA) for 20 minutes. Participants will complete sentence completion and verb generation task during stimulation.
Sham stimulation involves the delivery of 60 seconds of the actual stimulation waveform ("ramp up") which is then gradually reduced to 0 milliamps (mA) ("ramp down"). Participants will complete sentence completion and verb generation task during stimulation.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Published Research Related to This Trial
Citations
The effect of transcranial alternating current stimulation on ...
The results demonstrated that the tACS group had a significant decrease in mean NIHSS scores, a larger increase in blood flow velocity, and a ...
Transcranial Alternating Current Stimulation (tACS) in ...
This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke as well as healthy language ...
Effect of transcranial direct current stimulation combined ...
tDCS combined with SLT demonstrates potential enhancement in language recovery on post-ischemic stroke aphasia. The combination may augment speech content, ...
A single-blind sham-controlled study - Brain Stimulation
We predicted that tACS over SMA would enhance the efficacy of SLT in chronic post-stroke aphasia, especially for improving speech comprehension.
5.
centerwatch.com
centerwatch.com/clinical-trials/listings/NCT04375722/transcranial-alternating-current-stimulation-tacs-in-aphasiaTranscranial Alternating Current Stimulation (tACS) in ...
This study will assess the effects of transcranial alternating current stimulation (tACS) on language recovery after stroke as well as healthy ...
NCT06092814 | tACS to Enhance Language Abilities
The goal of this study is to see if transcranial alternating current stimulation (tACS) can be used to enhance language abilities in people with post-stroke ...
Safety Review of transcranial Direct Current Stimulation in ...
Only 11.62% of published papers reported the occurrence of tDCS adverse effects in stroke patients. The most common was itching (70%), followed by burning ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.